Is Prostate-Specific Antigen Surveillance Necessary in Men with Benign Prostate Pathology following Radical Cystoprostatectomy for Bladder Cancer?

Publisher： Karger

E-ISSN： 1423-0399|85|4|466-469

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.85, Iss.4, 2010-11, pp. : 466-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance

By  

BJU INTERNATIONAL, Vol. 118, Iss. 4, 2016-10 ,pp. : 535-540

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of prostate‐specific antigen testing as a disease surveillance tool following radical prostatectomy

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3523-3530

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer

By  

Urologia Internationalis, Vol. 97, Iss. 1, 2016-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2015-01 ,pp. : 330-336

Karger

Access to resources Recommend Favorite

Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer

By  

Urologia Internationalis, Vol. 98, Iss. 3, 2017-02 ,pp. : 290-297

Karger

Access to resources Recommend Favorite